Black Birch
NDC 36987-2542

View dosage, usage, ingredients, routes, and UNII mappings.
Table of Contents
  1. Product Information
  2. Product Packages
  3. What is NDC 36987-2542?
  4. Black Birch Uses
  5. Active Ingredients UNII Codes
  6. Inactive Ingredients UNII Codes
  7. NDC to RxNorm Crosswalk

Product Information

This product is EXCLUDED from the official NDC directory because the listing data was inactivated by the FDA.

Black Birch is a BLA-approved product labeled by Nelco Laboratories, Inc.. This product is primarily utilized in pharmaceutical processing or compounding. It is supplied as a product. This product entry covers the primary NDC 36987-2542 and 4 associated package configurations. This profile includes active and inactive ingredient UNII references and FDA labeling data.

Primary Identification

NDC Product Code:
36987-2542
Proprietary Name:
Black Birch
Product Type: [3]
INACTIVATED PRODUCT and EXCLUDED the from NDC Directory
Code Navigator:

Labeler & Regulatory Data

Labeler Name: [5]
Nelco Laboratories, Inc.
Labeler Code:
36987
Product Label ID:
3baaac54-68e4-47a3-b0c7-fb9b5b8d6271
FDA Application Number: [6]
BLA102192
Marketing Category: [8]
BLA - A product marketed under an approved Biologic License Application.

Marketing Timeline

Start Marketing Date: [9]
08-29-1972
Listing Expiration Date: [11]
12-31-2017
Exclude Flag: [12]
I

Code Structure Chart

Product Details

What is NDC 36987-2542?

The NDC code 36987-2542 is assigned by the FDA to the product Black Birch. This pharmaceutical product is labeled by Nelco Laboratories, Inc. and is currently categorized as listed product. In terms of distribution, this product is available in 4 different package configurations. The associated package NDC(s) include: 36987-2542-1, 36987-2542-2, 36987-2542-3, 36987-2542-4. Beyond standard identification, this entry provides technical data including pharmacologic classes, UNII ingredient references, and RxNorm cross-referencing for healthcare systems.

What are the uses of this product?

Allergenic extracts are indicated for use in diagnostic testing and as part of a treatment regime for allergic disease, as established by allergy history and skin test reactivity. Allergenic extracts are indicated for the treatment of allergen specific allergic disease for use as hyposensitization or immunotherapy when avoidance of specific allergens can not be attained. The use of allergenic extracts for therapeutic purpose has been established by well-controlled clinical studies. Allergenic extracts may be used as adjunctive therapy along with pharmacotherapy which includes antihistamines, corticosteroids, and cromoglycate, and avoidance measures. Allergenic extracts for therapeutic use should be given using only the allergen selection to which the patient is allergic, has a history of exposure and are likely to be exposed to again.

Which are the associated UNII Codes?

The UNII codes for the active ingredients in this product are:

  • ACACIA BAILEYANA POLLEN (UNII: 59WAV8G5X5)
  • ACACIA BAILEYANA POLLEN (UNII: 59WAV8G5X5) (Active Moiety)
  • ALNUS RUBRA POLLEN (UNII: Z0F2YK1B7H)
  • ALNUS RUBRA POLLEN (UNII: Z0F2YK1B7H) (Active Moiety)
  • ALNUS INCANA SUBSP. RUGOSA POLLEN (UNII: 605T96G8Y5)
  • ALNUS INCANA SUBSP. RUGOSA POLLEN (UNII: 605T96G8Y5) (Active Moiety)
  • ALNUS RHOMBIFOLIA POLLEN (UNII: 7X8HL8GRTM)
  • ALNUS RHOMBIFOLIA POLLEN (UNII: 7X8HL8GRTM) (Active Moiety)
  • FRAXINUS VELUTINA POLLEN (UNII: LJT6I6Z8FD)
  • FRAXINUS VELUTINA POLLEN (UNII: LJT6I6Z8FD) (Active Moiety)
  • FRAXINUS LATIFOLIA POLLEN (UNII: 1FH355G8HF)
  • FRAXINUS LATIFOLIA POLLEN (UNII: 1FH355G8HF) (Active Moiety)
  • FRAXINUS AMERICANA POLLEN (UNII: G684LX721Q)
  • FRAXINUS AMERICANA POLLEN (UNII: G684LX721Q) (Active Moiety)
  • POPULUS TREMULOIDES POLLEN (UNII: 928OC2TJDA)
  • POPULUS TREMULOIDES POLLEN (UNII: 928OC2TJDA) (Active Moiety)
  • MORELLA CERIFERA POLLEN (UNII: LC8MEV9S89)
  • MORELLA CERIFERA POLLEN (UNII: LC8MEV9S89) (Active Moiety)
  • FAGUS GRANDIFOLIA POLLEN (UNII: 34X886W1H4)
  • FAGUS GRANDIFOLIA POLLEN (UNII: 34X886W1H4) (Active Moiety)
  • CASUARINA EQUISETIFOLIA POLLEN (UNII: OZJ4OE173N)
  • CASUARINA EQUISETIFOLIA POLLEN (UNII: OZJ4OE173N) (Active Moiety)
  • BETULA NIGRA POLLEN (UNII: 93963RFO1P)
  • BETULA NIGRA POLLEN (UNII: 93963RFO1P) (Active Moiety)
  • BETULA LENTA POLLEN (UNII: JQ5HI5004M)
  • BETULA LENTA POLLEN (UNII: JQ5HI5004M) (Active Moiety)

Which are the Inactive Ingredients associated UNII Codes?

The inactive ingredients are all the component of a medicinal product OTHER than the active ingredient(s). The acronym "UNII" stands for “Unique Ingredient Identifier” and is used to identify each inactive ingredient present in a product. The UNII codes for the inactive ingredients in this product are:

What is the NDC to RxNorm Crosswalk for this product?

RxNorm is a normalized naming system for generic and branded drugs that assigns unique concept identifier(s) known as RxCUIs to NDC products.The NDC to RxNorm Crosswalk for this produdct indicates multiple concept unique identifiers (RXCUIs) are associated with this product:
  • RxCUI: 1006474 - mango blossom pollen extract 10000 UNT/ML Injectable Solution
  • RxCUI: 1006474 - Mangifera indica pollen extract 10,000 UNT/ML Injectable Solution
  • RxCUI: 1006480 - black oak pollen extract 10000 UNT/ML Injectable Solution
  • RxCUI: 1006480 - Quercus velutina pollen extract 10,000 UNT/ML Injectable Solution
  • RxCUI: 1013878 - eastern white pine pollen extract 10,000 UNT/ML Injectable Solution

* Please review the full disclaimer at the bottom of this page.

Product & Regulatory Definitions
What is the Labeler Name? Name of Company corresponding to the labeler code segment of the Product NDC.
What is the FDA Application Number? This corresponds to the NDA, ANDA, or BLA number reported by the labeler for products which have the corresponding Marketing Category designated. If the designated Marketing Category is OTC Monograph Final or OTC Monograph Not Final, then the Application number will be the CFR citation corresponding to the appropriate Monograph (e.g. “part 341”). For unapproved drugs, this field will be null.
What is the Marketing Category? Product types are broken down into several potential Marketing Categories, such as NDA/ANDA/BLA, OTC Monograph, or Unapproved Drug. One and only one Marketing Category may be chosen for a product, not all marketing categories are available to all product types. Currently, only final marketed product categories are included. The complete list of codes and translations can be found at www.fda.gov/edrls under Structured Product Labeling Resources.
What is the Start Marketing Date? This is the date that the labeler indicates was the start of its marketing of the drug product.
What is the Listing Expiration Date? This is the date when the listing record will expire if not updated or certified by the product labeler.
What is the NDC Exclude Flag? This field indicates whether the product has been removed/excluded from the NDC Directory for failure to respond to FDA"s requests for correction to deficient or non-compliant submissions, or because the listing certification is expired, or because the listing data was inactivated by FDA, or because it was discontinued by the labeler. Possible values in this field are: "D", "E", "I", "N", "U".